Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Medline Inc. (MDLN) trades at a P/S ratio of 1.1×. Over the past ten years it has ranged from 0.0× (March 2026) to 1.4× (April 2026); the current reading is higher than 80% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.0× (12.87%)
Jun 2026 1.1× (10.51%)
Mar 2026 1.3× —
Dec 2025 0.0× —
2 more quarters

Against its own ten years

Low 0.0× High 1.4×
Ten-year median 1.0×
Current reading's percentile 80

P/S ratio against peers

Company P/S ratio
BAX Baxter International Inc. compare 1.1×
MDLN Medline Inc. 1.1×
SOLV Solventum Corporation compare 1.8×
BDX Becton, Dickinson and Company compare 2.8×
COO The Cooper Companies, Inc. compare 2.9×
ALC Alcon compare 3.4×
RMD ResMed Inc. compare 6.0×
WST West Pharmaceutical Services, Inc. compare 8.1×
ISRG Intuitive Surgical, Inc. compare 14.0×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MDLN